Meridian Bioscience signs new Canadian distribution agreement with Somagen
Jack Kraeutler, CEO of Meridian Bioscience, said: “The effective global distribution of our rapid tests for infectious disease is one of Meridian’s key strategies. By working closely with
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.